In a finding that offers the first evidence that the human papillomavirus (HPV) vaccine is indeed protecting women from cervical cancer, new research shows cases in the United States have slowly but steadily declined over the last decade and a half.
Researchers from Laval University, Canada, have found that five to eight years after vaccination there was a significant reduction in the prevalence of multiple types of human papillomavirus (HPV) and related conditions across the developed world.